Sun Pharma gets USFDA nod for cancer treatment injection

Sun Pharma gets USFDA nod for cancer drug

Sun Pharma said it had received approval from the U.S. health regulator for its Infugem injection used for treatment of cancer. This is the first USFDA approval for a product from the firm’s Halol facility after receipt of the Establishment Inspection Report in June 2018, Sun Pharma said. The approval is for Infugem injection (gemcitabine in 0.9% sodium chloride injection) 10 mg/mL, for intravenous use in a ready-to-administer bag.PTI

Source: Read Full Article